|1||NCT03811223||Not yet recruiting||Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia||
||30||All||18 Years and older (Adult, Older Adult)||NCT03811223||UMCU-VASC-CO-002||EVOLVE-FD||August 2019||January 2021||March 2021||January 21, 2019||January 21, 2019|
|2||NCT00001168||Recruiting||Evaluation of Lipoproteins||
||2000||All||2 Years to 99 Years (Child, Adult, Older Adult)||NCT00001168||790100
|January 1, 1979||November 4, 1999||February 15, 2019||
† Study has passed its completion date and status has not been verified in more than two years.